📣 VC round data is live. Check it out!

Cementos Bio-Bio Valuation Multiples

Discover revenue and EBITDA valuation multiples for Cementos Bio-Bio and similar public comparables like Titan USJE Skopje, Ibstock, Caribbean Cement Company, Marshalls and more.

Cementos Bio-Bio Overview

About Cementos Bio-Bio

Cementos Bio-Bio SA is a cement manufacturing company. The company manufactures and distributes construction materials.


Founded

1957

HQ

Chile

Employees

2.9K

Financials (FY)

Revenue: $408M
EBITDA: $56M

EV

$593M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cementos Bio-Bio Financials

Cementos Bio-Bio reported last fiscal year revenue of $408M and EBITDA of $56M.

In the same fiscal year, Cementos Bio-Bio generated $157M in gross profit, $56M in EBITDA, and $36M in net income.


Cementos Bio-Bio P&L

In the most recent fiscal year, Cementos Bio-Bio reported revenue of $408M and EBITDA of $56M.

Cementos Bio-Bio is profitable as of last fiscal year, with gross margin of 39%, EBITDA margin of 14%, and net margin of 9%.

See analyst estimates for Cementos Bio-Bio
Last FY202320242025202620272028
Revenue$408M$384M$396M$408M
Gross Profit$157M$142M$151M$157M
Gross Margin39%37%38%39%
EBITDA$56M$48M$60M$56M
EBITDA Margin14%13%15%14%
EBIT Margin12%10%11%12%
Net Profit$36M$25M$36M$36M
Net Margin9%7%9%9%
Net Debt$54M

Financial data powered by Morningstar, Inc.

Cementos Bio-Bio Stock Performance

Cementos Bio-Bio has current market cap of $504M, and enterprise value of $593M.

Market Cap Evolution


Cementos Bio-Bio's stock price is $1.91.

Cementos Bio-Bio share price decreased by 0.4% in the last 30 days, and increased by 8.0% in the last year.

Cementos Bio-Bio has an EPS (earnings per share) of $0.14.

See more trading valuation data for Cementos Bio-Bio
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$593M$504M-1.5%-0.4%-2.5%8.0%$0.14

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cementos Bio-Bio Valuation Multiples

Cementos Bio-Bio trades at 1.5x EV/Revenue multiple, and 10.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Cementos Bio-Bio

Cementos Bio-Bio Financial Valuation Multiples

As of May 17, 2026, Cementos Bio-Bio has market cap of $504M and EV of $593M.

Cementos Bio-Bio has a P/E ratio of 13.8x.

Last FY202320242025202620272028
EV/Revenue1.5x1.5x1.5x1.5x
EV/EBITDA10.6x12.3x9.8x10.6x
EV/EBIT12.3x15.8x14.1x12.3x
EV/Gross Profit3.8x4.2x3.9x3.8x
P/E13.8x20.1x14.1x13.8x
EV/FCF11.5x23.3x9.9x11.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cementos Bio-Bio Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cementos Bio-Bio Margins & Growth Rates

In the most recent fiscal year, Cementos Bio-Bio reported gross margin of 39%, EBITDA margin of 14%, and net margin of 9%.

See estimated margins and future growth rates for Cementos Bio-Bio

Cementos Bio-Bio Margins

Last FY20242025202720282029
Gross Margin39%38%39%
EBITDA Margin14%15%14%
EBIT Margin12%11%12%
Net Margin9%9%9%
FCF Margin13%15%13%

Cementos Bio-Bio Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth3%3%
Gross Profit Growth6%4%
EBITDA Growth25%(7%)
EBIT Growth12%14%
Net Profit Growth42%2%
FCF Growth134%(14%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Cementos Bio-Bio Operational KPIs

Cementos Bio-Bio's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Cementos Bio-Bio
Last FY202320242025202620272028
Revenue per Employee$0.1M
Opex per Employee$0.0M
S&M Expenses to Revenue15%18%16%15%
G&A Expenses to Revenue4%3%4%4%
Opex to Revenue27%27%28%27%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cementos Bio-Bio Competitors

Cementos Bio-Bio competitors include Titan USJE Skopje, Ibstock, Caribbean Cement Company, Marshalls, Konya Çimento, Eastern Province Cement, Vulcan Steel, PPC, Vassilico Cement Works and Forterra.

Most Cementos Bio-Bio public comparables operate across Building Materials.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Titan USJE Skopje4.3x10.6x
Ibstock1.4x1.4x7.4x7.5x
Caribbean Cement Company2.3x7.1x
Marshalls0.8x0.8x6.0x5.8x
Konya Çimento3.2x19.1x
Eastern Province Cement1.8x6.5x
Vulcan Steel1.6x1.4x12.5x12.3x
PPC1.0x0.9x6.6x5.1x

This data is available for Pro users. Sign up to see all Cementos Bio-Bio competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cementos Bio-Bio

When was Cementos Bio-Bio founded?Cementos Bio-Bio was founded in 1957.
Where is Cementos Bio-Bio headquartered?Cementos Bio-Bio is headquartered in Chile.
How many employees does Cementos Bio-Bio have?As of today, Cementos Bio-Bio has over 2K employees.
Is Cementos Bio-Bio publicly listed?Yes, Cementos Bio-Bio is a public company listed on Bolsa de Santiago.
What is the stock symbol of Cementos Bio-Bio?Cementos Bio-Bio trades under CEMENTOS ticker.
When did Cementos Bio-Bio go public?Cementos Bio-Bio went public in 1982.
Who are competitors of Cementos Bio-Bio?Cementos Bio-Bio main competitors include Titan USJE Skopje, Ibstock, Caribbean Cement Company, Marshalls, Konya Çimento, Eastern Province Cement, Vulcan Steel, PPC, Vassilico Cement Works, Forterra.
What is the current market cap of Cementos Bio-Bio?Cementos Bio-Bio's current market cap is $504M.
What is the current revenue of Cementos Bio-Bio?Cementos Bio-Bio's last fiscal year revenue is $408M.
What is the current EV/Revenue multiple of Cementos Bio-Bio?Current revenue multiple of Cementos Bio-Bio is 1.5x.
Is Cementos Bio-Bio profitable?No, Cementos Bio-Bio is not profitable.
How many companies Cementos Bio-Bio has acquired to date?Cementos Bio-Bio hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Cementos Bio-Bio has invested to date?Cementos Bio-Bio hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Cementos Bio-Bio

Lists including Cementos Bio-Bio

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial